Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73,224Revenue $M24,708Net Margin (%)11.4Altman Z-Score2.1
Enterprise Value $M79,262EPS $1.1Operating Margin %16.7Piotroski F-Score6
P/E(ttm)26.7Beneish M-Score-2.7Pre-tax Margin (%)12.4Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %4.9Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-16.1Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow42.2y-y EBITDA Growth Rate %-16.0ROA % (ttm)5.0Higher Current Ratio y-yN
Dividend Yield %4.8PEG--ROE % (ttm)15.7Less Shares Outstanding y-yN
Payout Ratio %125Shares Outstanding M2,528ROIC % (ttm)15.6Gross Margin Increase y-yY

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNKen Fisher 2016-03-31 Add$27.95 - $33.95
($30.11)
$ 28.96-4%Add 5.33%233,409
AZNDodge & Cox 2015-12-31 Buy 0.39%$30.47 - $34.77
($32.84)
$ 28.96-12%New holding11,777,132
AZNNWQ Managers 2015-12-31 Add0.01%$30.47 - $34.77
($32.84)
$ 28.96-12%Add 5.24%516,215
AZNKen Fisher 2015-12-31 Add0.01%$30.47 - $34.77
($32.8)
$ 28.96-12%Add 692.95%221,606
AZNNWQ Managers 2015-09-30 Add0.09%$30.28 - $34.54
($32.89)
$ 28.96-12%Add 60.04%490,535
AZNKen Fisher 2015-09-30 Buy $30.28 - $34.54
($32.89)
$ 28.96-12%New holding27,947
AZNMario Gabelli 2015-09-30 Sold Out $30.28 - $34.54
($32.89)
$ 28.96-12%Sold Out0
AZNDavid Dreman 2015-06-30 Sold Out -0.16%$31.86 - $36.68
($34.25)
$ 28.96-15%Sold Out0
AZNNWQ Managers 2015-06-30 Add0.12%$31.86 - $36.68
($34.25)
$ 28.96-15%Add 486.45%306,510
AZNMario Gabelli 2015-06-30 Reduce$31.86 - $36.68
($34.25)
$ 28.96-15%Reduce -28.81%8,400
AZNDavid Dreman 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.77)
$ 28.96-17%Reduce -4.43%54,978
AZNNWQ Managers 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.77)
$ 28.96-17%Reduce -21.34%104,530
AZNMario Gabelli 2015-03-31 Reduce$32.22 - $36.35
($34.77)
$ 28.96-17%Reduce -40.70%23,600
AZNDavid Dreman 2014-12-31 Reduce-0.51%$33.58 - $37.69
($35.82)
$ 28.96-19%Reduce -75.42%57,528
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$33.58 - $37.69
($35.82)
$ 28.96-19%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$33.58 - $37.69
($35.82)
$ 28.96-19%Reduce -52.51%39,800
AZNNWQ Managers 2014-12-31 Add$33.58 - $37.69
($35.82)
$ 28.96-19%Add 3.05%132,880
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$34.25 - $38.16
($36.64)
$ 28.96-21%Sold Out0
AZNMario Gabelli 2014-09-30 Add$34.25 - $38.16
($36.64)
$ 28.96-21%Add 3.71%83,800
AZNDavid Dreman 2014-09-30 Reduce$34.25 - $38.16
($36.64)
$ 28.96-21%Reduce -0.70%234,006
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1770.35view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Francis Chou Raises Stake in Resolute Forest Products Mar 20 2016 
    Signature Select Canadian Fund Second Quarter 2015 Market Commentary Sep 22 2015 
    Francis Chou Doubles Stake in AstraZeneca Aug 11 2015 
    Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 

    More From Other Websites
    Are Provident Financial plc and Rexam plc better income stocks than AstraZeneca plc? May 01 2016
    Europe close: Risk appetite falls ahead of long weekend, US jobs report Apr 29 2016
    AstraZeneca, Pfizer Said Among Firms Weighing Medivation Bid Apr 29 2016
    [$$] AstraZeneca cuts costs for shift to cancer drugs Apr 29 2016
    AstraZeneca cuts costs and doubles down on cancer drugs Apr 29 2016
    AstraZeneca cuts costs and doubles down on cancer drugs Apr 29 2016
    AstraZeneca cuts costs and doubles down on cancer drugs Apr 29 2016
    AstraZeneca First Quarter Fails to Ease Growth Worries Apr 29 2016
    AstraZeneca first-quarter revenue up, earnings down Apr 29 2016
    Do today’s results make AstraZeneca plc & Laird PLC the ultimate dividend buys? Apr 29 2016
    Europe open: Stocks follow Wall St into the red Apr 29 2016
    4:16 am AstraZeneca misses by $0.01, beats on revs; reaffirms FY16 EPS guidance, revs guidance Apr 29 2016
    AstraZeneca 1Q Core Earnings Per Share Misses Estimate Apr 29 2016
    AstraZeneca 1Q Core Earnings Per Share Misses Estimate Apr 29 2016
    AstraZeneca says it will cut costs Apr 29 2016
    AstraZeneca says it will cut costs Apr 29 2016
    Drugmaker AstraZeneca's earnings fall, hit by patent expiries Apr 29 2016
    Drugmaker AstraZeneca's earnings fall, hit by patent expiries Apr 29 2016
    AstraZeneca Profit Falls as Recent Purchases Push Up Costs Apr 29 2016
    How Will AstraZeneca (AZN) Stock React to Upcoming Q1 Earnings? Apr 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)